Ipsogen, a company that markets molecular diagnostics assays for leukaemia, has launched MapQuant DxT Genomic Grade. The new assay is a molecular diagnostic test for breast tumour grade, which is an indicator of tumour proliferation, metastasis risk and response to chemotherapy.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Barbican Centre, London; and online.
28 April - 1 May
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
28 April, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 May, 2026
Leonardo Royal Hotel, 245 Broad St, Birmingham, B1 2HQ
5 May, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
6 May, 2026
